Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John C Byrd

Showing results (1-10 of 680) with videos related to

Pageof 68
Sort By:
Clinical Advances in Hematology & Oncology : H&O|April 10, 2015
Traditional treatment approaches in chronic lymphocytic leukemiaJohn C Byrd
Blood|March 9, 2019
Targeting CD20 takes the backseat in CLLJohn C Byrd
Journal of the National Comprehensive Cancer Network : JNCCN|May 24, 2014
Chronic lymphocytic leukemia: state of the art and beyondJohn C Byrd
Blood|June 13, 2015
Introduction to a series of reviews on chronic lymphocytic leukemiaJohn C Byrd
Clinical Advances in Hematology & Oncology : H&O|October 15, 2005
Antibody therapy in chronic lymphocytic leukemiaJohn C Byrd
Blood|July 21, 2018
HSP90 inhibition without heat shock responseJohn C Byrd
Blood|December 8, 2009
Hunting for the Achilles' heel of CLLJohn C Byrd
The New England Journal of Medicine|May 3, 2023
Zanubrutinib in Chronic Lymphocytic LeukemiaJohn C Byrd, Wayne Rothbaum
Blood|February 16, 2013
UGT2B17 as a disease accelerator in CLLYiming Zhong, John C Byrd
Cancer Discovery|September 3, 2017
Spotlight on Ibrutinib in PCNSL: Adding Another Feather to Its CapAparna Lakshmanan, John C Byrd
Pageof 68

Showing results (1-10 of 680) with videos related to

Sort By:
Pageof 68
Clinical Advances in Hematology & Oncology : H&O|April 10, 2015
Traditional treatment approaches in chronic lymphocytic leukemiaJohn C Byrd
Blood|March 9, 2019
Targeting CD20 takes the backseat in CLLJohn C Byrd
Journal of the National Comprehensive Cancer Network : JNCCN|May 24, 2014
Chronic lymphocytic leukemia: state of the art and beyondJohn C Byrd
Blood|June 13, 2015
Introduction to a series of reviews on chronic lymphocytic leukemiaJohn C Byrd
Clinical Advances in Hematology & Oncology : H&O|October 15, 2005
Antibody therapy in chronic lymphocytic leukemiaJohn C Byrd
Blood|July 21, 2018
HSP90 inhibition without heat shock responseJohn C Byrd
Blood|December 8, 2009
Hunting for the Achilles' heel of CLLJohn C Byrd
The New England Journal of Medicine|May 3, 2023
Zanubrutinib in Chronic Lymphocytic LeukemiaJohn C Byrd, Wayne Rothbaum
Blood|February 16, 2013
UGT2B17 as a disease accelerator in CLLYiming Zhong, John C Byrd
Cancer Discovery|September 3, 2017
Spotlight on Ibrutinib in PCNSL: Adding Another Feather to Its CapAparna Lakshmanan, John C Byrd
Pageof 68